4//SEC Filing
Kanes Stephen 4
Accession 0001562180-19-000858
CIK 0001597553other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:08 PM ET
Size
7.2 KB
Accession
0001562180-19-000858
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-02-08$150.00/sh−22,948$3,442,200→ 941 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The 941 shares reported as beneficially owned were acquired by the reporting person pursuant to the issuer's employee stock purchase plan.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612859
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:08 PM ET
- Size
- 7.2 KB